Navigation Links
ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
Date:3/18/2011

as designated an orphan medicinal product on October 8, 2009. Upon granting of a Centralized Marketing Authorization and retention of the orphan medicinal product designation, Cinryze would be entitled to a period of 10 years market exclusivity in respect of the approved therapeutic indication. This 10-year market exclusivity period could be extended cumulatively to 12 years when the results of all studies conducted in compliance with an agreed pediatric investigation plan are completed and included in the summary of product characteristics.

About Cinryze® (C1 esterase inhibitor [human])

Cinryze is a highly purified, pasteurized and nanofiltered plasma-derived C1 esterase inhibitor product.  In the U.S., Cinryze was approved by FDA for routine prophylaxis against angioedema attacks in adolescent and adult patients with HAE.  In the E.U., the recommended indication is for treatment and pre-procedure prevention of angioedema attacks in adults and adolescents with hereditary angioedema (HAE), and routine prevention of angioedema attacks in adults and adolescents with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments or patients who are inadequately managed with repeated acute treatment.

Severe hypersensitivity reactions to Cinryze may occur.  Thrombotic events have occurred in patients receiving Cinryze for routine prophylaxis, and in patients receiving off-label high dose C1 inhibitor therapy.  Monitor patients with known risk factors for thrombotic events.  With any blood or plasma derived product, there may be a risk of transmission of infectious agents, e.g. viruses and, theoretically, the CJD agent. The risk has been reduced by screening donors for prior exposure to certain virus infections and by manufacturing steps to reduce the risk of viral transmission including pasteurization and nanofiltration.  <
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015  Holographic Optical Technologies of Augusta, ... medical imaging, is entering the world of consumer electronics ... April 20 th , 2015, the campaign will introduce ... and 22-inch displays will allow consumers to view fully ... In addition to the two displays, the company will ...
(Date:3/27/2015)... -- A new report from Kalorama Information says that other ... Chile , Colombia and ... firms.  The healthcare research firm said that while ... Latin American continent with a population of over 200 million ... the country,s regional economic clout does not necessarily ensure its ...
(Date:3/27/2015)... LONDON , March 27, 2015 ... commercial prospects for leading ophthalmic drug companies  ... the pharma ophthalmic industry ? Visiongain,s brand new ... trends, opportunities and prospects there. Our 242-page ... most lucrative areas in the industry and the future ...
Breaking Medicine Technology:Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7
... SALT LAKE CITY, June 04, 2007 /PRNewswire-FirstCall/ -- ... a 340 patient,randomized Phase III clinical trial testing ... presented at the annual,American Society of Clinical Oncology ... results of this clinical study,which was conducted at ...
... III Data Presented at ASCO -, CHICAGO, ... that Soliris(TM) (eculizumab), a new treatment for,paroxysmal ... , is effective in patients diagnosed with ... (AA) or myelodysplastic,syndromes (MDS). Soliris significantly reduced ...
Cached Medicine Technology:Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival,Compared to Chemotherapy Alone for Sarcoma Cancer Patients 2Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival,Compared to Chemotherapy Alone for Sarcoma Cancer Patients 3Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 2Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 3Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 5Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 6Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 7
(Date:3/28/2015)... 2015 India Network visitor health ... available to all visitors who purchase the plan before ... are encouraged to purchase the insurance program as soon ... proper coverage for pre-existing medical conditions. Parents and grandparents ... medical conditions with serious consequences to their health. Many ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 How best ... a growing field in orthopaedic medicine. While diagnostic hip ... to confirm the pain etiology, research presented today at ... ) Specialty Day suggests that pain relief from this ... hip surgery. , “Our study looked to assess ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Lately the ... media regarding recent changes and proposals around the NCAA. ... current and former collegiate student-athletes across a spectrum of ... reflect on common challenges. The special panel consists of ... in sports ranging from football, track and field, baseball, ...
(Date:3/28/2015)... ARDX will sponsor the 7th Annual Women’s Wellness ... Chesapeake Conference Center in Chesapeake, Virginia. Each year, ARDX ... women in the Hampton Roads region. The 2015 Women’s ... Women grow stronger through sharing their stories and learning ... the WWC™ theme is T-talk where we will share a ...
(Date:3/27/2015)... Commack, Long Island, NY (PRWEB) March 27, 2015 ... standardized, objective, cancer-focused training and business criteria for the ... treatments and services to clients who have experienced or ... member of the global Spafinder Wellness 365® Network, will ... on Spafinder.com and recognized as a provider of safe, ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4
... , Only 40% of kids at age 8 use booster seats; half of parents with kids age 4-8 say they don,t know state laws requiring seat use , ... , ... ... ...
... with fibromyalgia experiences daily pain all over their body. Even something as simple as a handshake or hug ... the "Science of Fibromyalgia" as a resource to help people understand the underlying science behind fibromyalgia, a chronic, ... ... , ...
... may seem like a small matter. However, a nurse at ... were a constant source of anxiety for many patients receiving ... was rooted in myth instead of scientific evidence. ... Journal of Oncology Nursing , are prompting change locally and ...
... toll on blood pressure over time, causing a marked increase ... University of Chicago. A new study shows, for the ... in blood pressure four years latera link that is independent ... to rise, including body-mass index, smoking, alcohol use and demographic ...
... likely to be tipplers, study finds , WEDNESDAY, March 17 ... American adults consider themselves drinkers, a new U.S. government report ... women, and people with more education are the most likely ... abstained their whole lives. , The findings from the ...
... ... the new Absolute Health office. The new office is located at 13402 N Scottsdale Rd, ... ... allergy relief , chiropractic and biofeedback should consider visiting the ...
Cached Medicine News:Health News:Unaware of Laws, Many Parents Not Using Booster Seats for Older Children 2Health News:Unaware of Laws, Many Parents Not Using Booster Seats for Older Children 3Health News:Unaware of Laws, Many Parents Not Using Booster Seats for Older Children 4Health News:Unaware of Laws, Many Parents Not Using Booster Seats for Older Children 5Health News:Unaware of Laws, Many Parents Not Using Booster Seats for Older Children 6Health News:Unaware of Laws, Many Parents Not Using Booster Seats for Older Children 7Health News:VIDEO from Medialink and National Fibromyalgia Association and Pfizer Inc.: The Science Behind Fibromyalgia 2Health News:VIDEO from Medialink and National Fibromyalgia Association and Pfizer Inc.: The Science Behind Fibromyalgia 3Health News:Nurses' research settles a common cancer concern: Skin care 2Health News:Nurses' research settles a common cancer concern: Skin care 3Health News:Feeling lonely adds to rate of blood pressure increase in people 50 years old and older 2Health News:Feeling lonely adds to rate of blood pressure increase in people 50 years old and older 3Health News:6 Out of 10 American Adults Drink 2Health News:Allergy Relief, Chiropractic and Biofeedback Provided at New Absolute Health Clinic in Scottsdale, Arizona 2Health News:Allergy Relief, Chiropractic and Biofeedback Provided at New Absolute Health Clinic in Scottsdale, Arizona 3
... STA R is a fully ... for clotting, chromogenic and immunological, latex ... analyser using standard 5-position racks as ... 200 different methods, up to 70 ...
... Surgicutt family of bleeding time devices provides ... adults, Surgicutt Jr. for children and Surgicutt ... family is engineered to perfect the bleeding ... the variables that have previously hindered test ...
... tenderfoot infant heelstick device uses a highly sharpened ... a gentle arc. The incision produced is carefully ... where most nerve fibers are located, but through ... high quality blood sample with significantly less pain ...
The Unistik 3 family of single use safety lancets has 4 models for use across all clinical environments....
Medicine Products: